Amanda Anderson

749 total citations
21 papers, 493 citations indexed

About

Amanda Anderson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Amanda Anderson has authored 21 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Amanda Anderson's work include Prostate Cancer Treatment and Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer Genomics and Diagnostics (4 papers). Amanda Anderson is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer Genomics and Diagnostics (4 papers). Amanda Anderson collaborates with scholars based in United States, Canada and United Kingdom. Amanda Anderson's co-authors include Edward L. Nelson, N Molino, Szu‐Wen Wang, Howard I. Scher, Nicole A. Schreiber, Lori E. Lowes, Eric Winquist, Glenn Heller, Martin Fleisher and Anuradha Jayaram and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Amanda Anderson

19 papers receiving 489 citations

Peers

Amanda Anderson

PRM

ONCOL

IMMUN

Wenjun Liang China

Jun Xing China

Wenju Liu China

Shalini Jindal Australia

Raúl A. Ruggiero Argentina

Kristal L. Gant United States

W E Grizzle United States

Lijun Mao China

Cory L. Painter United States

Wenjun Liang China

Amanda Anderson

396 ×1.7

139 ×0.8

PRM

133 ×0.9

ONCOL

206 ×1.7

105 ×1.1

IMMUN

Citations per year, relative to Amanda Anderson Amanda Anderson (= 1×) peers Wenjun Liang

Countries citing papers authored by Amanda Anderson

Since Specialization

Citations

This map shows the geographic impact of Amanda Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Anderson more than expected).

Fields of papers citing papers by Amanda Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Anderson. The network helps show where Amanda Anderson may publish in the future.

Co-authorship network of co-authors of Amanda Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Anderson. A scholar is included among the top collaborators of Amanda Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Anderson. Amanda Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salunga, Ranelle, Wilma E. Mesker, Linda de Munck, et al.. (2025). Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index. Clinical Cancer Research. 31(11). 2222–2229. 1 indexed citations

Anderson, Amanda, et al.. (2025). Surgical Repair of Bilateral Achilles Tendon Rupture Following Levofloxacin Use. Cureus. 17(3). e80011–e80011. 1 indexed citations

Noori, Mohammad, et al.. (2024). Finite Element Analysis of the Bearing Component of Total Ankle Replacement Implants during the Stance Phase of the Gait Cycle. SHILAP Revista de lepidopterología. 4(3). 1949–1978.

Zhao, Jimmy L., Emmanuel S. Antonarakis, Heather H. Cheng, et al.. (2023). Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC). British Journal of Cancer. 130(1). 53–62. 13 indexed citations

Nieva, Jorge J., Janice Lu, Shelley Hwang, et al.. (2022). Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer. npj Breast Cancer. 8(1). 112–112. 16 indexed citations

Chapin, William J., Jacob E. Till, Wei‐Ting Hwang, et al.. (2022). Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma. JCO Precision Oncology. 6(6). e2200060–e2200060. 7 indexed citations

Zhang, Bingnan, C. Allison Stewart, Carl M. Gay, et al.. (2021). Abstract 384: Detection of DNA replication blocker SLFN11 in tumor tissue and circulating tumor cells to predict platinum response in small cell lung cancer. Cancer Research. 81(13_Supplement). 384–384. 6 indexed citations

Stöhr, Anke C., et al.. (2021). Axillary Leiomyosarcoma in an Inland Bearded Dragon (Pogona vitticeps). Journal of Herpetological Medicine and Surgery. 31(1). 12–17.

Zhao, Jimmy L., Emmanuel S. Antonarakis, Heather H. Cheng, et al.. (2021). 598P A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. 32. S643–S644. 2 indexed citations

10.

Scher, Howard I., Katherine Cunningham, Ethan Barnett, et al.. (2021). Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.. Journal of Clinical Oncology. 39(15_suppl). e17039–e17039. 3 indexed citations

11.

Daisley, Brendan A., Ryan M. Chanyi, Kait F. Al, et al.. (2020). Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients. Nature Communications. 11(1). 4822–4822. 88 indexed citations

12.

Daisley, Brendan A., Ryan M. Chanyi, Kait F. Al, et al.. (2020). Author Correction: Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients. Nature Communications. 11(1). 6394–6394. 4 indexed citations

13.

Anderson, Amanda, et al.. (2019). CTC enumeration and characterization as a pharmacodynamic marker in the phase I clinical study of APX3330, an APE1/Ref-1 inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. 37(15_suppl). e14531–e14531. 9 indexed citations

14.

Anderson, Amanda, et al.. (2019). Abstract 3885: Evaluation of pharmacokinetics of proxalutamide, a novel androgen receptor antagonist, in treatment for mCRPC patients via CTC enumeration and AR biomarker analysis. Cancer Research. 79(13_Supplement). 3885–3885. 1 indexed citations

15.

Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2018). Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer. JAMA Oncology. 4(9). 1179–1179. 160 indexed citations

16.

Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2018). Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 36(6_suppl). 273–273. 7 indexed citations

17.

Jia, Shidong, Sarah K. Baird, Amanda Anderson, et al.. (2016). Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 34(2_suppl). 195–195. 1 indexed citations

18.

Anderson, Amanda, et al.. (2014). Expression of prostate-specific membrane antigen (PSMA) on circulating tumor cells (CTCs) in castration-resistant prostate cancer.. Journal of Clinical Oncology. 32(4_suppl). 266–266. 3 indexed citations

19.

Molino, N, Amanda Anderson, Edward L. Nelson, & Szu‐Wen Wang. (2013). Biomimetic Protein Nanoparticles Facilitate Enhanced Dendritic Cell Activation and Cross-Presentation. ACS Nano. 7(11). 9743–9752. 128 indexed citations

20.

Biegler, Kelly A., Amanda Anderson, Lari Wenzel, Kathryn Osann, & Edward L. Nelson. (2012). Longitudinal Change in Telomere Length and the Chronic Stress Response in a Randomized Pilot Biobehavioral Clinical Study: Implications for Cancer Prevention. Cancer Prevention Research. 5(10). 1173–1182. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact